Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.86 USD | +1.99% | -3.03% | -20.44% |
Mar. 14 | Transcript : Exact Sciences Corporation - Special Call | |
Mar. 05 | Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 2.83B | Sales 2025 * | 3.23B | Capitalization | 10.68B |
---|---|---|---|---|---|
Net income 2024 * | -161M | Net income 2025 * | 4M | EV / Sales 2024 * | 4.3 x |
Net Debt 2024 * | 1.51B | Net Debt 2025 * | 1.09B | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
-66.8
x | P/E ratio 2025 * |
3,128
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.69% |
Latest transcript on Exact Sciences Corporation
1 day | +1.99% | ||
1 week | -3.03% | ||
Current month | +2.31% | ||
1 month | -3.46% | ||
3 months | -8.89% | ||
6 months | -21.83% | ||
Current year | -20.44% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Jeffrey Elliott
DFI | Director of Finance/CFO | 46 | 16-06-19 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Freda Lewis-Hall
BRD | Director/Board Member | 68 | 20-04-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 58.86 | +1.99% | 1,747,922 |
24-03-15 | 57.71 | -1.40% | 1,854,884 |
24-03-14 | 58.53 | -4.17% | 1,893,200 |
24-03-13 | 61.08 | +0.63% | 1,381,502 |
24-03-12 | 60.7 | 0.00% | 1,819,048 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.44% | 10.68B | |
+72.57% | 3.92B | |
-6.29% | 2.56B | |
-35.49% | 2.12B | |
-21.56% | 1.62B | |
+21.53% | 1.05B | |
+5.46% | 840M | |
-17.58% | 512M | |
-35.10% | 461M | |
+10.80% | 250M |